Proprotein Convertase Subtilisin/kexin Type 9(Pcsk9) Inhibitors - Medical Necessity Request Form Page 3

ADVERTISEMENT

Member Name: ______________________________ Member ID: ________________ Member DOB: ________________
Drug Name: _____________________________ Strength: _______________ Directions: ______________________________________
Physician Name: __________________________ Physician Phone #: _________________________ Specialty: _____________________
Physician Fax #: _____________________ Pharmacy Name: ____________________________Pharmacy Phone: __________________
Complete this page for Subsequent Request
General Questions:
1.
If member is female: Is the member pregnant? Yes or No
2.
Will the member be receiving another PCSK-9 inhibitor? Yes or No
3.
Will the member continue to receive the requested drug together with ezetimibe (Zetia)?
□ Yes
□ No – if not, why is the Zetia being discontinued:_____________________________________________________________
4.
Will the member continue to receive the requested drug together with a maximum intensity statin (atorvastatin 40-80mg,
Rosuvastatin 20-40mg)?
□ Yes, please provide name of medications__________________________________________________________________
Dates filled____________________________________________________________________________________________
Pharmacy name: _______________________________________________________________________________________
Pharmacy phone number: ________________________________________________________________________________
□ No - if not,
a. Why is the statin being discontinued______________________________________________________________
b. Will a lower statin dose be prescribed instead?
□ Yes - Why is lower dose being use instead?________________________________________________
□ No - if not, why not____________________________________________________________________
5.
Please provide the current LDL-C taken within the past 30 days and date taken.
- Level: _____________mg/dL
Date Taken: ______________ *Please fax over lab report confirming this level.
Diagnosis Information (please indicate diagnosis and answer related questions):
□ Homozygous familial hypercholesterolemia (HoFH)
-
Will the member be receiving lomitapide (Juxtapid) or mipomersen (Kynamro) concurrently with this medication? Yes or No
□ Heterozygous familial hypercholesterolemia (HeFH)
□ Clinical Atherosclerotic Cardiovascular Disease (ASCVD)
Physician office's signature*_________________________________ Print Name________________________________
*Form must be completed and signed by physician or licensed representative from the physician’s office
3 of 3
Rev. 3/16
HNJH Fax #: 888-567-0681
Page

ADVERTISEMENT

00 votes

Related Articles

Related forms

Related Categories

Parent category: Medical
Go
Page of 3